Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Quanterix Corp (QTRX)

Quanterix Corp (QTRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Tue Jun 16, 3:01PM CDT

Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that...

QTRX : 4.29 (-0.92%)
Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer Business Wire - Tue Jun 9, 7:03AM CDT

Quanterix Corporation (Nasdaq: QTRX) , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Jason Faessler...

QTRX : 4.29 (-0.92%)
Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics Business Wire - Thu Jun 4, 7:02AM CDT

Strategic Leadership Addition Signals Drive to Expand Diagnostics Business

QTRX : 4.29 (-0.92%)
Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference Business Wire - Wed Jun 3, 7:01AM CDT

Quanterix Corporation (Nasdaq: QTRX) , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that senior management will participate...

QTRX : 4.29 (-0.92%)
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Tue May 26, 3:01PM CDT

Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that...

QTRX : 4.29 (-0.92%)
Quanterix Announces Planned Transition of Chief Financial Officer Business Wire - Tue May 12, 3:01PM CDT

Quanterix Corporation (Nasdaq: QTRX) , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that Vandana Sriram, its Chief Financial...

QTRX : 4.29 (-0.92%)
Quanterix Releases Financial Results for the First Quarter of 2026 Business Wire - Wed May 6, 3:01PM CDT

Reports $36.4 million in revenue and approximately $103 million of cash and marketable securities Company prioritizing product roadmap and investing in initiatives to...

QTRX : 4.29 (-0.92%)
Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows Business Wire - Wed May 6, 7:00AM CDT

Agreement supports the identification of patients eligible for Alzheimer’s disease biomarker testing through Tempus Next and enables neurologists to order LucentAD® Complete on Tempus’ clinical ordering...

TEM : 60.38 (+0.18%)
QTRX : 4.29 (-0.92%)
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026 Business Wire - Fri Apr 24, 7:33AM CDT

Quanterix Corporation (Nasdaq: QTRX) , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call...

QTRX : 4.29 (-0.92%)
AidaBREAST™ Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology Business Wire - Fri Apr 17, 7:33AM CDT

Novel Assay, Developed on Akoya PhenoImager HT Platform with Opal Chemistry, Becomes First to Predict Both Locoregional Recurrence Risk and Radiation Therapy Benefit in Early-Stage Invasive Breast Cancer...

QTRX : 4.29 (-0.92%)

Barchart Exclusives

Has the Bond Market Missed the Oil Collapse? The Case for Lower Treasury Yields Into Early September Barchart - 1 minute ago
Crude oil has fallen back into the $60-$70 range, inflation fears are fading, and traders are pricing in a less restrictive Fed. Could Treasury yields be the next market to catch up?We break down the fundamentals, seasonals, and technicals, pointing toward lower yields into early September. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.